Clinical trials: Kidney Transplant Candidates
Kidney Transplant
Pilot Social Support Counseling Intervention for Kidney Transplant Candidates
Feasibility pilot social support counseling intervention for kidney transplant candidates
- Trial name
- NCT04363515
- Testing
- Social support network counseling intervention
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Allyson Hart
Highly Sensitized Patients on Waiting List for Kidney Transplantation
Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
Viela Bio is conducting an open-label, randomized study of inebilizumab, VIB4920, or the combination as part of a multi-center study in highly sensitized patients on the deceased donor waiting list for kidney transplantation.
- Trial name
- NCT04174677
- Testing
- Inebilizumab, VIB4920, Inebilzumab+VIB4920
- Where
- 2 sites in United States
- Sponsor
- Amgen
Cardiovascular Risk Factor, Diabetes Mellitus, Type 1
Cardiopulmonary Testing for Potential Pancreas Transplant Candidates
Patients being assessed for Kidney Pancreas transplantation often have pre-existing co-morbid disease that contributes to structural cardiac and vascular disease.
- Conditions
- Cardiovascular Risk Factor, Diabetes Mellitus, Type 1, Pancreas Transplant; Complications
- Trial name
- NCT04312802
- Testing
- Cardiopulmonary exercise test (CPET)
- Where
- United Kingdom
- Volunteers
- 10 people
- Sponsor
- Oxford University Hospitals NHS Trust
Kidney Disease, Kidney Transplant
Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation
This is a study for hypersensitized patients who have been waiting for more than 3 years for an offer for a kidney transplant. The objective is to perform a transplant of autologous hematopoietic precursors with the aim of…
- Conditions
- Kidney Disease, Kidney Transplant, Kidney Transplant Candidates
- Trial name
- RESET (NCT06809075)
- Testing
- hematopoietic precursor transplantation (TPHa)
- Where
- Spain
- Volunteers
- 10 people
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
End Stage Renal Disease, Kidney Transplantation
Desensitization of Renal Transplant Candidates
Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.
- Trial name
- NCT00298883
- Testing
- Myfortic
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Florida
Chronic Kidney Disease Stage 5, Periodontal Disease
Response to Periodontal Therapy in a Chronic Kidney Disease Population
This study will evaluate periodontal and systemic parameters of a cohort of chronic kidney disease (stage 5) patients, before and three months after non-surgical periodontal treatment. It does not consider a control group.
- Trial name
- NCT03525457
- Testing
- Non Surgical Periodontal Therapy
- Where
- Chile
- Volunteers
- 65 people
- Sponsor
- Pontificia Universidad Catolica de Chile
Kidney Transplant Candidates
Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients
This is a Phase II, pilot, prospective, unicentric trial, to evaluate Imlifidase could improve the transplantability of the highly sensitized patients with good outcomes respect to survival and functionality of the graft.
- Trial name
- LIVEDES (NCT06461546)
- Testing
- Imlifidase
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica
Kidney Transplantation
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
Patients planning to have kidney transplantation who are sensitized to their donors have high levels of donor specific alloantibodies.
- Trial name
- NCT00722722
- Testing
- Bortezomib
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Mayo Clinic